Bioxytran, Inc.
BIXT
$0.02
$0.005.42%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 3.21M | 2.93M | 1.39M | 1.24M | 1.04M |
| Depreciation & Amortization | 14.80K | 11.70K | 11.50K | 11.50K | 8.80K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.71M | 3.27M | 1.85M | 1.74M | 1.58M |
| Operating Income | -3.71M | -3.27M | -1.85M | -1.74M | -1.58M |
| Income Before Tax | -3.49M | -2.84M | -2.12M | -2.35M | -2.46M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -3.49 | -2.84 | -2.12 | -2.35 | -2.46 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | 0.00 | 0.00 |
| Net Income | -3.49M | -2.84M | -2.12M | -2.35M | -2.46M |
| EBIT | -3.71M | -3.27M | -1.85M | -1.74M | -1.58M |
| EBITDA | -3.69M | -3.26M | -1.85M | -1.73M | -1.58M |
| EPS Basic | -0.03 | -0.03 | -0.02 | -0.03 | -0.03 |
| Normalized Basic EPS | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 |
| EPS Diluted | -0.03 | -0.03 | -0.02 | -0.03 | -0.03 |
| Normalized Diluted EPS | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 |
| Average Basic Shares Outstanding | 416.18M | 390.66M | 367.22M | 359.60M | 397.00M |
| Average Diluted Shares Outstanding | 416.18M | 390.66M | 367.22M | 359.60M | 397.00M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |